A self-reported Brazilian registry of 5q-spinal muscular atrophy: data on natural history, genetic characteristics, and multidisciplinary care

A self-reported Brazilian registry of 5q-spinal muscular atrophy: data on natural history, genetic characteristics, and multidisciplinary care

Background Spinal muscular atrophy linked to chromosome 5q (SMA-5q) is a neurodegenerative disorder caused by mutations in the SMN1 gene.

Saved in:

Bibliographic Details
Main Authors:	Rodrigo Holanda Mendonça, Juliane Suellen Arndt de Godoi, Edmar Zanoteli
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações 2024-12-01
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	Muscular Atrophy, Spinal Survival of Motor Neuron 1 Protein Natural History Registries Atrofia Muscular Espinal Proteína 1 de Sobrevivência do Neurônio Motor História Natural Sistema de Registros
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1792096
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Type-1 spinal muscular atrophy cohort before and after disease-modifying therapies
by: Brenda Klemm Arci Mattos de Freitas Alves, et al.
Published: (2024-11-01)

Consensus from the Brazilian Academy of Neurology for the diagnosis, genetic counseling, and use of disease-modifying therapies in 5q spinal muscular atrophy
by: Edmar Zanoteli, et al.
Published: (2024-01-01)

Therapeutic advances in 5q-linked spinal muscular atrophy
by: Umbertina Conti Reed, et al.

Atrofia muscular progressiva: estudo clínico e laboratorial em onze pacientes
by: Maria Elisabeth Matta de Rezende Ferraz, et al.
Published: (2004-03-01)

X-linked spinal and bulbar muscular atrophy (Kennedy's disease) with long-term electrophysiological evaluation: case report Atrofia muscular bulbo-espinal ligada ao cromossomo X (doença de Kennedy) com seguimento eletrofisiológico de longo prazo: relato de caso
by: João Aris Kouyoumdjian, et al.
Published: (2005-03-01)

Managing intrathecal administration of nusinersen in adolescents and adults with 5q-spinal muscular atrophy and previous spinal surgery
by: Rodrigo de Holanda Mendonça, et al.

Spinal muscular atrophy type II (intermediary) and III (Kugelberg-Welander): evolution of 50 patients with physiotherapy and hydrotherapy in a swimming pool Atrofia muscular espinhal tipo II (intermediária) e III (Kugelberg-Welander): evolução de 50 pacientes com fisioterapia e hidroterapia em piscina
by: Márcia C. B. Cunha, et al.
Published: (1996-09-01)

Spinal muscular atrophy type 1 in the Caribbean: the first case report from the Dominican Republic
by: María Belén Martín-Sanz, et al.
Published: (2025-01-01)

Dificuldades diagnósticas na atrofia muscular espinhal Spinal muscular atrophy diagnostic difficulties
by: Alexandra Prufer de Q-C. Araújo, et al.
Published: (2005-03-01)

Brazilian version of the CHOP INTEND scale: cross-cultural adaptation and validation
by: Renalli Manuella Rodrigues Alves, et al.
Published: (2023-09-01)

Primary hyperparathyroidism simulating motor neuron disease: case report Hiperparatiroidismo primário simulando doença do neurônio motor: relato de caso
by: Alzira Alves Siqueira Carvalho, et al.
Published: (2005-03-01)

Longitudinal data collection in pediatric and adult patients with 5q spinal muscular atrophy in Latin America: LATAM RegistrAME study - a clinical registry study protocol
by: Elice Carneiro Batista, et al.
Published: (2024-12-01)

Why should a 5q spinal muscular atrophy neonatal screening program be started?
by: Michele Michelin Becker, et al.
Published: (2024-10-01)

Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort
by: Ömer Bektaş, et al.
Published: (2025-03-01)

Congenital contractural arachnodactyly with neurogenic muscular atrophy: case report
by: Rosana Herminia Scola, et al.
Published: (2001-06-01)

Brazilian version of the Hammersmith Functional Motor Scale Expanded: cross-cultural adaptation and validation
by: Ana Carolina Monteiro Lessa de Moura, et al.
Published: (2024-07-01)

Benign monomelic amyotrophy: a study of twenty-one cases Amiotrofia monomélica benigna: estudo de 21 casos
by: MARCOS R.G. DE FREITAS, et al.
Published: (2000-09-01)

Efectos de la suplementación con creatina monohidratada en la masa muscular y rendimiento físico en adultos jóvenes entrenados: una revisión sistemática
by: Bastián Parada-Flores, et al.
Published: (2024-11-01)

Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016Research in context
by: Maria Carmela Pera, et al.
Published: (2024-12-01)

Adult-onset non-5q proximal spinal muscular atrophy: a comprehensive review
by: Wladimir Bocca Vieira de Rezende Pinto, et al.
Published: (2021-01-01)

Adult spinal muscular atrophy: problems of early diagnosis
by: Yu. A. Shpilyukova, et al.
Published: (2022-12-01)

Efficacy of Nusinersen Treatment in Type 1, 2, and 3 Spinal Muscular Atrophy: Real-World Data from a Single-Center Study
by: Anna Lemska, et al.
Published: (2024-10-01)

Familial adult spinal muscular atrophy associated with the VAPB gene: report of 42 cases in Brazil
by: Victor Kosac, et al.
Published: (2013-10-01)

Quantitative and structural features of the SMN1 and SMN2 genes in patients with spinal muscular atrophy 5q
by: A. I. Vlasenko, et al.
Published: (2024-12-01)

Gene therapy in neuromuscular disorders
by: Rodrigo Holanda Mendonça, et al.
Published: (2022-08-01)

Insights into diagnostic difficulties in spinal muscular atrophy: a Case Report series
by: Kakha Bregvadze, et al.
Published: (2024-12-01)

Non-progressive juvenile spinal muscular atrophy of the distal upper limb (Hirayama's disease): a clinical variant of the benign monomelic amyotrophy
by: NASCIMENTO OSVALDO J. M., et al.
Published: (2000-01-01)

Spinal muscular atrophy in the era of newborn screening: how the classification could change
by: Antonio Varone, et al.
Published: (2025-05-01)

Gene-based therapies for neuromuscular disorders
by: Edmar Zanoteli, et al.
Published: (2024-06-01)

Common complications in spinal muscular atrophy (SMA) type 1 after nusinersen treatment
by: Yiğithan Güzin, et al.
Published: (2024-11-01)

Rehabilitation management for patients with spinal muscular atrophy: a review
by: Wei Song, et al.
Published: (2025-07-01)

Concomitant telomere attrition is associated with spinal muscular atrophy in highly inbred region of North India: unraveling the thread in Kashmir region
by: Rukhsana Hassan, et al.
Published: (2024-11-01)

Diagnostic criteria for spinal muscular atrophy 5q
by: I. V. Sharkova, et al.
Published: (2021-12-01)

Expanding the phenotype of DYNC1H1-associated diseases with a rare variant resulting in spinal muscular atrophy with lower extremity predominance (SMA-LED) and upper motor neuron signs
by: Jessica Lee, et al.
Published: (2023-06-01)

Functional class criteria identification in patients with spinal muscular atrophy 5q
by: Yu. O. Papina, et al.
Published: (2024-12-01)

Physical and Respiratory Rehabilitation in Spinal Muscular Atrophy: A Critical Narrative Review
by: Serena Cammarano, et al.
Published: (2025-04-01)

The social-economic burden of spinal muscular atrophy in Russia
by: A. S. Kolbin, et al.
Published: (2021-02-01)

Experience of Nusinersen in children with proximal spinal muscular atrophy 5q in Moscow region
by: M. V. Panteleeva
Published: (2022-12-01)

The Life-Saving Impact of Early Diagnosis and Treatment for Spinal Muscular Atrophy Type 1
by: Almas Siddique, et al.
Published: (2025-04-01)

Factors modifying the course of spinal muscular atrophy 5q
by: M. A. Akhkiamova, et al.
Published: (2024-01-01)